ID   HES1_HUMAN              Reviewed;         280 AA.
AC   Q14469; Q6FHB2;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 213.
DE   RecName: Full=Transcription factor HES-1;
DE   AltName: Full=Class B basic helix-loop-helix protein 39;
DE            Short=bHLHb39;
DE   AltName: Full=Hairy and enhancer of split 1;
DE   AltName: Full=Hairy homolog;
DE   AltName: Full=Hairy-like protein;
DE            Short=hHL;
GN   Name=HES1; Synonyms=BHLHB39, HL, HRY;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8020957; DOI=10.1006/geno.1994.1126;
RA   Feder J.N., Li L., Jan L.Y., Jan Y.-N.;
RT   "Genomic cloning and chromosomal localization of HRY, the human homolog to
RT   the Drosophila segmentation gene, hairy.";
RL   Genomics 20:56-61(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RA   Yao J., Yeung S., Sun H., Chen N.;
RT   "Functional analysis of human HRY in Drosophila.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   INTERACTION WITH SIRT1.
RX   PubMed=12535671; DOI=10.1016/s0006-291x(02)03020-6;
RA   Takata T., Ishikawa F.;
RT   "Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1
RT   and HEY2 and is involved in HES1- and HEY2-mediated transcriptional
RT   repression.";
RL   Biochem. Biophys. Res. Commun. 301:250-257(2003).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH FA COMPLEX.
RX   PubMed=18550849; DOI=10.1182/blood-2008-04-152710;
RA   Tremblay C.S., Huang F.F., Habi O., Huard C.C., Godin C., Levesque G.,
RA   Carreau M.;
RT   "HES1 is a novel interactor of the Fanconi anemia core complex.";
RL   Blood 112:2062-2070(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   SUBCELLULAR LOCATION, AND UBIQUITINATION (MICROBIAL INFECTION).
RX   PubMed=28750047; DOI=10.1371/journal.ppat.1006542;
RA   Liu X.J., Yang B., Huang S.N., Wu C.C., Li X.J., Cheng S., Jiang X., Hu F.,
RA   Ming Y.Z., Nevels M., Britt W.J., Rayner S., Tang Q., Zeng W.B., Zhao F.,
RA   Luo M.H.;
RT   "Human cytomegalovirus IE1 downregulates Hes1 in neural progenitor cells as
RT   a potential E3 ubiquitin ligase.";
RL   PLoS Pathog. 13:e1006542-e1006542(2017).
CC   -!- FUNCTION: Transcriptional repressor of genes that require a bHLH
CC       protein for their transcription. May act as a negative regulator of
CC       myogenesis by inhibiting the functions of MYOD1 and ASH1. Binds DNA on
CC       N-box motifs: 5'-CACNAG-3' with high affinity and on E-box motifs: 5'-
CC       CANNTG-3' with low affinity (By similarity). May play a role in a
CC       functional FA core complex response to DNA cross-link damage, being
CC       required for the stability and nuclear localization of FA core complex
CC       proteins, as well as for FANCD2 monoubiquitination in response to DNA
CC       damage. {ECO:0000250, ECO:0000269|PubMed:18550849}.
CC   -!- SUBUNIT: Transcription repression requires formation of a complex with
CC       a corepressor protein of the Groucho/TLE family. Interacts (via WPRW
CC       motif) with TLE1, and more weakly with TLE2. Interacts with HES6 (By
CC       similarity). Interacts with SIRT1. Interacts with an FA complex,
CC       composed of FANCA, FANCF, FANCG and FANCL, but not of FANCC, nor FANCE.
CC       {ECO:0000250, ECO:0000269|PubMed:12535671,
CC       ECO:0000269|PubMed:18550849}.
CC   -!- INTERACTION:
CC       Q14469; Q96EB6: SIRT1; NbExp=4; IntAct=EBI-2832522, EBI-1802965;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28750047}.
CC   -!- DOMAIN: Has a particular type of basic domain (presence of a helix-
CC       interrupting proline) that binds to the N-box (CACNAG), rather than the
CC       canonical E-box (CANNTG).
CC   -!- DOMAIN: The C-terminal WRPW motif is a transcriptional repression
CC       domain necessary for the interaction with Groucho/TLE family members,
CC       transcriptional corepressors recruited to specific target DNA by Hairy-
CC       related proteins. {ECO:0000250}.
CC   -!- DOMAIN: The bHLH, as well as cooperation between the central Orange
CC       domain and the C-terminal WRPW motif, is required for transcriptional
CC       repressor activity. {ECO:0000250}.
CC   -!- PTM: (Microbial infection) Ubiquitinated via human cytomegalovirus/HCMV
CC       protein IE1 that assembles a HES1 ubiquitination complex; leading to
CC       HES1 proteasomal degradation. {ECO:0000269|PubMed:28750047}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L19314; AAA65220.1; -; Genomic_DNA.
DR   EMBL; AF264785; AAF73060.1; -; mRNA.
DR   EMBL; AK000415; BAA91149.1; -; mRNA.
DR   EMBL; CR541843; CAG46641.1; -; mRNA.
DR   CCDS; CCDS3305.1; -.
DR   PIR; A53027; A53027.
DR   RefSeq; NP_005515.1; NM_005524.4.
DR   PDB; 2MH3; NMR; -; A/B=27-95.
DR   PDB; 7C4O; NMR; -; A/B=103-150.
DR   PDBsum; 2MH3; -.
DR   PDBsum; 7C4O; -.
DR   AlphaFoldDB; Q14469; -.
DR   BMRB; Q14469; -.
DR   SMR; Q14469; -.
DR   BioGRID; 109514; 52.
DR   CORUM; Q14469; -.
DR   ELM; Q14469; -.
DR   FunCoup; Q14469; 1885.
DR   IntAct; Q14469; 19.
DR   MINT; Q14469; -.
DR   STRING; 9606.ENSP00000232424; -.
DR   ChEMBL; CHEMBL3734643; -.
DR   GlyGen; Q14469; 3 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q14469; -.
DR   PhosphoSitePlus; Q14469; -.
DR   BioMuta; HES1; -.
DR   DMDM; 3913825; -.
DR   jPOST; Q14469; -.
DR   MassIVE; Q14469; -.
DR   PaxDb; 9606-ENSP00000232424; -.
DR   PeptideAtlas; Q14469; -.
DR   ProteomicsDB; 60000; -.
DR   Pumba; Q14469; -.
DR   Antibodypedia; 19442; 650 antibodies from 40 providers.
DR   DNASU; 3280; -.
DR   Ensembl; ENST00000232424.4; ENSP00000232424.3; ENSG00000114315.4.
DR   GeneID; 3280; -.
DR   KEGG; hsa:3280; -.
DR   MANE-Select; ENST00000232424.4; ENSP00000232424.3; NM_005524.4; NP_005515.1.
DR   UCSC; uc003ftq.3; human.
DR   AGR; HGNC:5192; -.
DR   CTD; 3280; -.
DR   DisGeNET; 3280; -.
DR   GeneCards; HES1; -.
DR   HGNC; HGNC:5192; HES1.
DR   HPA; ENSG00000114315; Low tissue specificity.
DR   MalaCards; HES1; -.
DR   MIM; 139605; gene.
DR   OpenTargets; ENSG00000114315; -.
DR   VEuPathDB; HostDB:ENSG00000114315; -.
DR   eggNOG; KOG4304; Eukaryota.
DR   GeneTree; ENSGT00940000159619; -.
DR   HOGENOM; CLU_068550_1_0_1; -.
DR   InParanoid; Q14469; -.
DR   OMA; AMNYPAQ; -.
DR   OrthoDB; 6085656at2759; -.
DR   PAN-GO; Q14469; 9 GO annotations based on evolutionary models.
DR   PhylomeDB; Q14469; -.
DR   PathwayCommons; Q14469; -.
DR   Reactome; R-HSA-210744; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2197563; NOTCH2 intracellular domain regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.
DR   Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
DR   Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-9013695; NOTCH4 Intracellular Domain Regulates Transcription.
DR   SignaLink; Q14469; -.
DR   SIGNOR; Q14469; -.
DR   BioGRID-ORCS; 3280; 34 hits in 1196 CRISPR screens.
DR   ChiTaRS; HES1; human.
DR   EvolutionaryTrace; Q14469; -.
DR   GeneWiki; HES1; -.
DR   GenomeRNAi; 3280; -.
DR   Pharos; Q14469; Tbio.
DR   PRO; PR:Q14469; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q14469; protein.
DR   Bgee; ENSG00000114315; Expressed in renal medulla and 205 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; ISS:ARUK-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0043398; F:HLH domain binding; IEA:Ensembl.
DR   GO; GO:0008432; F:JUN kinase binding; IEA:Ensembl.
DR   GO; GO:0071820; F:N-box binding; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0051087; F:protein-folding chaperone binding; IEA:Ensembl.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:ARUK-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0001222; F:transcription corepressor binding; IEA:Ensembl.
DR   GO; GO:0021984; P:adenohypophysis development; IEA:Ensembl.
DR   GO; GO:0035881; P:amacrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0048844; P:artery morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0035910; P:ascending aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0021870; P:Cajal-Retzius cell differentiation; IEA:Ensembl.
DR   GO; GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; IEA:Ensembl.
DR   GO; GO:0001709; P:cell fate determination; IEA:Ensembl.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0048667; P:cell morphogenesis involved in neuron differentiation; IEA:Ensembl.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0072049; P:comma-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0061009; P:common bile duct development; IEA:Ensembl.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0090162; P:establishment of epithelial cell polarity; IEA:Ensembl.
DR   GO; GO:0021861; P:forebrain radial glial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0072012; P:glomerulus vasculature development; IEA:Ensembl.
DR   GO; GO:0021575; P:hindbrain morphogenesis; IEA:Ensembl.
DR   GO; GO:0042491; P:inner ear auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0060716; P:labyrinthine layer blood vessel development; IEA:Ensembl.
DR   GO; GO:0046331; P:lateral inhibition; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0072282; P:metanephric nephron tubule morphogenesis; IEA:Ensembl.
DR   GO; GO:0030901; P:midbrain development; IEA:Ensembl.
DR   GO; GO:0021555; P:midbrain-hindbrain boundary morphogenesis; IEA:Ensembl.
DR   GO; GO:1902870; P:negative regulation of amacrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0090281; P:negative regulation of calcium ion import; IEA:Ensembl.
DR   GO; GO:1905934; P:negative regulation of cell fate determination; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:BHF-UCL.
DR   GO; GO:2000978; P:negative regulation of forebrain neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045608; P:negative regulation of inner ear auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IBA:GO_Central.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:2000227; P:negative regulation of pancreatic A cell differentiation; IEA:Ensembl.
DR   GO; GO:2000974; P:negative regulation of pro-B cell differentiation; IMP:UniProtKB.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB.
DR   GO; GO:0061106; P:negative regulation of stomach neuroendocrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021557; P:oculomotor nerve development; IEA:Ensembl.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003310; P:pancreatic A cell differentiation; IEA:Ensembl.
DR   GO; GO:0061626; P:pharyngeal arch artery morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:BHF-UCL.
DR   GO; GO:0043388; P:positive regulation of DNA binding; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0045977; P:positive regulation of mitotic cell cycle, embryonic; ISS:BHF-UCL.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISS:UniProtKB.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045598; P:regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0050767; P:regulation of neurogenesis; IBA:GO_Central.
DR   GO; GO:0043254; P:regulation of protein-containing complex assembly; IEA:Ensembl.
DR   GO; GO:0046425; P:regulation of receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0003266; P:regulation of secondary heart field cardioblast proliferation; IEA:Ensembl.
DR   GO; GO:0060164; P:regulation of timing of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0072141; P:renal interstitial fibroblast development; IEA:Ensembl.
DR   GO; GO:0043279; P:response to alkaloid; IEA:Ensembl.
DR   GO; GO:0097066; P:response to thyroid hormone; IEA:Ensembl.
DR   GO; GO:0009615; P:response to virus; IEA:Ensembl.
DR   GO; GO:0072050; P:S-shaped body morphogenesis; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IEA:Ensembl.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0061102; P:stomach neuroendocrine cell differentiation; IEA:Ensembl.
DR   GO; GO:0042098; P:T cell proliferation; IEA:Ensembl.
DR   GO; GO:0021537; P:telencephalon development; IEA:Ensembl.
DR   GO; GO:0048538; P:thymus development; ISS:BHF-UCL.
DR   GO; GO:0021558; P:trochlear nerve development; IEA:Ensembl.
DR   GO; GO:0060675; P:ureteric bud morphogenesis; IEA:Ensembl.
DR   GO; GO:0097084; P:vascular associated smooth muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0003281; P:ventricular septum development; ISS:BHF-UCL.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
DR   CDD; cd11459; bHLH-O_HES1_4; 1.
DR   FunFam; 4.10.280.10:FF:000009; Transcription factor HES-1; 1.
DR   Gene3D; 6.10.250.980; -; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   IDEAL; IID00211; -.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR050370; HES_HEY.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR003650; Orange_dom.
DR   PANTHER; PTHR10985; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR, HES-RELATED; 1.
DR   Pfam; PF07527; Hairy_orange; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00511; ORANGE; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   SUPFAM; SSF158457; Orange domain-like; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS51054; ORANGE; 1.
DR   neXtProt; NX_Q14469; -.
DR   PharmGKB; PA29465; -.
DR   TreeFam; TF351373; -.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Nucleus; Proteomics identification;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..280
FT                   /note="Transcription factor HES-1"
FT                   /id="PRO_0000127202"
FT   DOMAIN          34..91
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          110..143
FT                   /note="Orange"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00380"
FT   REGION          1..44
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          157..200
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          254..280
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           275..278
FT                   /note="WRPW motif"
FT   COMPBIAS        10..21
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        26..35
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        164..174
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        181..200
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        254..271
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   STRAND          31..33
FT                   /evidence="ECO:0007829|PDB:2MH3"
FT   HELIX           40..65
FT                   /evidence="ECO:0007829|PDB:2MH3"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:2MH3"
FT   HELIX           77..93
FT                   /evidence="ECO:0007829|PDB:2MH3"
FT   HELIX           104..125
FT                   /evidence="ECO:0007829|PDB:7C4O"
FT   HELIX           133..149
FT                   /evidence="ECO:0007829|PDB:7C4O"
SQ   SEQUENCE   280 AA;  29541 MW;  F9342A88FC749E3C CRC64;
     MPADIMEKNS SSPVAATPAS VNTTPDKPKT ASEHRKSSKP IMEKRRRARI NESLSQLKTL
     ILDALKKDSS RHSKLEKADI LEMTVKHLRN LQRAQMTAAL STDPSVLGKY RAGFSECMNE
     VTRFLSTCEG VNTEVRTRLL GHLANCMTQI NAMTYPGQPH PALQAPPPPP PGPGGPQHAP
     FAPPPPLVPI PGGAAPPPGG APCKLGSQAG EAAKVFGGFQ VVPAPDGQFA FLIPNGAFAH
     SGPVIPVYTS NSGTSVGPNA VSPSSGPSLT ADSMWRPWRN
//
